In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[Q]: Rare Earths and Critical Materials Revitalization Act of 2010 - Title I: Rare Earth Materials - (Sec. 101) Establishes in the Department of Energy (DOE) a research, development, and commercial application program to assure the long-term, secure, and sustainable supply of specified rare earth materials to satisfy the national security, economic well-being, and industrial production needs of the United States.

Directs the Secretary of Energy (Secretary) to: (1) support new or significantly improved processes and technologies (as compared to those currently in use in the rare earth materials industry); (2) encourage multidisciplinary collaborations and opportunities for students at institutions of higher education; (3) collaborate with relevant agencies of foreign countries with interests relating to rare earth materials; and (4) submit an implementation plan to Congress.

Requires the Secretary to offer to contract with the National Academy of Sciences for an assessment of the program after it has been in operation for four years.

(Sec. 102) Amends the Energy Policy Act of 2005 to authorize the Secretary through FY 2015, only to the extent provided in advance in a subsequent appropriations Act, to make loan guarantee commitments for the commercial application of new or significantly improved technologies for specified categories of projects, including: (1) separation and recovery of rare earth materials from ores or other sources; (2) preparation of rare earth materials in oxide, metal, alloy, or other forms needed for national security, economic well-being, or industrial production purposes; and (3) application of rare earth materials in the production of improved magnets, batteries, refrigeration systems, optical systems, electronics, and catalysis, among other uses.

Directs the Secretary to cooperate with appropriate private sector participants to achieve a complete rare earth materials production capability in the United States within five years after enactment of this Act.

Prohibits the Secretary from awarding a loan guarantee for a project unless the project's proponent provides assurances that the loan or guarantee shall be used to support the separation, recovery, preparation, or manufacturing of rare earth materials in the United States for customers within the United States, unless insufficient domestic demand for such materials results in excess capacity.

Title II: National Materials and Minerals Policy, Research, and Development - (Sec. 201) Amends the National Materials and Minerals Policy, Research and Development Act of 1980 to: (1) instruct the Director of the Office of Science and Technology Policy to coordinate federal materials research and development through the National Science and Technology Council (instead of the Federal Coordinating Council for Science, Engineering, and Technology, which is now defunct); and (2) repeal specified reporting and action requirements for the Secretaries of Defense and of the Interior, respectively.

(Sec. 202) Repeals the National Critical Materials Act of 1984.
[A]: To develop a rare earth materials program, to amend the National Materials and Minerals Policy, Research and Development Act of 1980, and for other purposes.


[Q]: Santa Ana River Water Supply Enhancement Act of 2009 - Amends the Reclamation Wastewater and Groundwater Study and Facilities Act to authorize the Secretary of the Interior, in cooperation with: (1) the Orange County Water District (the District), to participate in the design, planning, and construction of natural treatment systems and wetlands for the flows of the Santa Ana River, California, and its tributaries into the Prado Basin; (2) local governments, to assist agencies in projects to construct regional brine lines to export the salinity imported from the Colorado River to the Pacific Ocean; and (3) the Chino Basin Watermaster, the Inland Empire Utilities Agency, and the Santa Ana Watershed Project Authority, to participate in the design, planning, and construction of the Lower Chino Dairy Area desalination demonstration and reclamation project. Limits the federal share of total project costs. Prohibits using funds provided by the Secretary for operation and maintenance of the projects. Terminates the Secretary's authority to carry out this Act after 10 years.
[A]: To amend the Reclamation Wastewater and Groundwater Study and Facilities Act to authorize the Secretary of the Interior to participate in the Prado Basin Natural Treatment System Project, to authorize the Secretary to carry out a program to assist agencies in projects to construct regional brine lines in California, to authorize the Secretary to participate in the Lower Chino Dairy Area desalination demonstration and reclamation project, and for other purposes.


[Q]: Antibiotic Development to Advance Patient Treatment Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to authorize the Secretary of Health and Human Services (HHS) to approve the use of an antibacterial or antifungal drug that is intended for treatment of a serious or life-threatening disease or condition to treat a limited population of patients for which there is an unmet medical need. Requires the labeling of such drugs to prominently include in the prescribing information the statement that the drug is indicated for use in a limited and specific population of patients. Amends the Public Health Service Act to authorize the Secretary to license those antibacterial or antifungal drugs as biological products. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) monitor the use of antibacterial and antifungal drugs, (2) monitor changes in bacterial and fungal resistance to drugs, and (3) make the information derived from such monitoring available to the public. Amends the FFDCA to direct the Secretary: (1) to identify upon approval, and subsequently update, susceptibility test interpretive criteria for antibacterial drugs by relying upon preclinical and clinical data, Bayesian and pharmacometric statistical methodologies, and such other confirmatory evidence the Secretary deems necessary; (2) on a quarterly basis, to evaluate new or updated criteria published by a nationally or internationally recognized standard development organization; and (3) to publish on the Food and Drug Administration's (FDA's) website a notice adopting, declining to adopt, or partially adopting such new or updated criteria.      
[A]:
Antibiotic Development to Advance Patient Treatment Act of 2013